Delivery Order SPE2DB20D3505-SPE2DB24FT2Y0

Award Date 10/27/23
Potential Completion Date 10/30/23
Potential Value $12K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,164.74 firm fixed-price delivery order is for SYNVISC-ONE SYRINGE 6ML, a medical product, with a period of performance through March 14, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,910.00 Firm Fixed Price Delivery Order is for the supply of SYNVISC-ONE SYRINGE 6ML, a medical product, to support federal healthcare programs. The contract has a performance period through July 26, 2024 and was not set aside for any specific business type. Amerisourcebergen holds a significant $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,773.68 firm fixed-price delivery order is for the supply of SYNVISC-ONE SYRINGE 6ML, a medical product, with a period of performance through February 5, 2025. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,274.60 firm fixed-price delivery order is for the supply of SYNVISC-ONE SYRINGE 6ML, a medical product used for various healthcare applications. The contract has an ultimate completion date of October 29, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award to AmerisourceBergen Drug Corp (a major pharmaceutical distributor) is a delivery order valued at $1,251.76 for the supply of SYNVISC-ONE SYRINGE 6ML, a medical product, to the Defense Logistics Agency (DLA). The contract has an ultimate completion date of August 30, 2024 and is a firm-fixed price arrangement. AmerisourceBergen holds a larger indefinite delivery contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999 through December 2025 for...
This federal contract award from the Defense Logistics Agency (DLA) was made to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,562.24 firm-fixed-price delivery order is for the supply of SYNVISC-ONE SYRINGE 6ML, a medical product, with a period of performance through March 17, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the supply of various pharmaceutical products and medical supplies. The contract has a ceiling value of $11,615.83 and is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the...
This federal contract award, valued at $198,634.53, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to provide a...
This federal contract award, valued at $6,460.32, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the provision of SYNVISC-ONE SYRINGE 6ML, a medical product, with a performance period ending on March 7, 2025. The contract has a Firm Fixed Price pricing type and does not have a set-aside designation, indicating open competition. In addition to this...
This federal contract award with ID SPE2DB24D1034|SPE2DB25FWBG6 was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $23,632.93 firm fixed-price delivery order is for SYNVISC SYRINGE 2ML medical supplies. The contract has an ultimate completion date of March 20, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November...
  • SPE2DB20D3505
    Indefinite Delivery Contract
  • SPE2DB20D3505-SPE2DB24FT2Y0
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $11,927.19 firm fixed-price delivery order is for the supply of SYNVISC-ONE SYRINGE 6ML medical products. The contract has an ultimate completion date of October 30, 2023.

Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies for federal healthcare beneficiaries. This specific award was not designated with any set-aside requirements, indicating open competition.

Generated 2/27/25, 11:40 AM